The Patent Finder

Sanofi Pasteur Inc.

37 patents currently held · Updated Nov 21, 2026
50 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 7 name spellings.

4
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 4 to 30, 2027 · next Jan 4
  • 1 fee due Aug 27, 2027
    The maintenance fee for Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition (US 11,911,452) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 1 fee due Sep 3, 2027
    The maintenance fee for Multimerization of Recombinant Protein by Fusion to a Sequence from Lamprey (US 10,577,398) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Methods of Cultivating Bordetella Species (US 11,970,690) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,067,566Dengue serotype 2 attenuated strain
In force
 · USPTO record
In forceUSPTO record
US 8,795,688Dengue serotype 2 attenuated strain
In force
 · USPTO record
In forceUSPTO record
US 7,641,907Dengue Serotype 1 Attenuated Strain
In force
 · High confidence
In forceHigh confidence
US 7,641,908Dengue Serotype 2 Attenuated Strain
In force
 · High confidence
In forceHigh confidence
US 9,019,496Method for Estimating the Amount of Entities Deposited on Microparticles in Suspension in a Solution, Associated Device and Use of Said Device
In force
 · High confidence
In forceHigh confidence
US 9,938,055Method of Storing a Vaccine Containing an Aluminum Adjuvant
In force
 · High confidence
In forceHigh confidence
US 9,365,832Purification of Herpes Virus
In force
 · High confidence
In forceHigh confidence
US 9,358,294Method for Formulating a Vaccine Containing at Least Two Antigens Capable of Adsorbing onto Aluminium Oxyhydroxide
In force
 · High confidence
In forceHigh confidence
US 10,363,304Purification of Herpes Virus
In force
 · High confidence
In forceHigh confidence
US 11,224,650Purification of Herpes Virus
In force
 · High confidence
In forceHigh confidence
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
Also on record, not counted in the 37: 50 patents in force now held by others · 93 lapsed for an unpaid fee · 37 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

30 pending · 44 abandoned · 6 no status recorded

Showing 1 to 10 of 80, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
19/235,094Systems and Methods for Designing VaccinesJun 11, 2025Pending
19/213,013Methods for Determining Adjuvanted Protein Concentration and Percent Adsorption Using Intrinsic FluorescenceMay 20, 2025Pending
19/196,288Respiratory Syncytial Virus Rna VaccinationMay 1, 2025Pending
19/046,019Compositions for Use in Treatment of ChlamydiaFeb 5, 2025Pending
19/022,412Neisseria Meningitidis VaccineJan 15, 2025Pending
19/020,003Human Cytomegalovirus Immunogenic CompositionJan 14, 2025Pending
18/978,229Compositions and Methods for Circular Rna Affinity PurificationDec 12, 2024Pending
18/899,212Primers and Probes for Detecting MycobacteriaSep 27, 2024Pending
18/746,742Meningococcal B Recombinant VaccineJun 18, 2024Pending
18/671,660Human Metapneumovirus Viral Vector-Based VaccinesMay 22, 2024Pending
10 of 80 applications shown.
Pro members see all 80 published applications.
Pro members: see all 80 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited